These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27139990)

  • 1. Deal watch: Bristol-Myers Squibb acquires potential keys to treating rheumatoid arthritis.
    Cully M
    Nat Rev Drug Discov; 2016 May; 15(5):301. PubMed ID: 27139990
    [No Abstract]   [Full Text] [Related]  

  • 2. Deal watch: Bristol-Myers Squibb and Exelixis collaborate on kinase inhibitors.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180098
    [No Abstract]   [Full Text] [Related]  

  • 3. Deal watch : BMS acquires rights for IL-6 inhibitor.
    Nat Rev Drug Discov; 2010 Jan; 9(1):10. PubMed ID: 20043020
    [No Abstract]   [Full Text] [Related]  

  • 4. Rituximab and abatacept for rheumatoid arthritis.
    BMJ Group
    Drug Ther Bull; 2008 Aug; 46(8):57-61. PubMed ID: 18687584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid arthritis market.
    Mount C; Featherstone J
    Nat Rev Drug Discov; 2005 Jan; 4(1):11-2. PubMed ID: 15690597
    [No Abstract]   [Full Text] [Related]  

  • 6. Bristol-Myers Squibb swallows last of antibody pioneers.
    Allison M
    Nat Biotechnol; 2009 Sep; 27(9):781-3. PubMed ID: 19741612
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic trials in paediatric rheumatology].
    Guillaume S; Koné-Paut I
    Arch Pediatr; 2008 Jun; 15(5):867-9. PubMed ID: 18582784
    [No Abstract]   [Full Text] [Related]  

  • 8. Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009: comments on the article by M Neovius et al.
    Ohlsson H; Merlo J
    Scand J Rheumatol; 2011 May; 40(3):243-4. PubMed ID: 21529245
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure to report previously used drugs and dosages in pharmaceutical company-sponsored rheumatoid arthritis trials: comment on the article by Yocum et al.
    Parker CT; Rennie T
    Arthritis Rheum; 2004 Sep; 50(9):3051; author reply 3051-2. PubMed ID: 15457479
    [No Abstract]   [Full Text] [Related]  

  • 10. Deal watch: Bristol-Myers Squibb invests in cancer antibody that targets the innate immune system.
    Nat Rev Drug Discov; 2011 Aug; 10(9):648. PubMed ID: 21878969
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug development in rheumatoid arthritis.
    Witter J
    Curr Opin Rheumatol; 2002 May; 14(3):276-80. PubMed ID: 11981326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. I take a disease-modifying antirheumatic drug (DMARD) for my rheumatoid arthritis pain. But is there a non-drug treatment or therapy I can use to deal with intermittent pain or flareups?
    Duke Med Health News; 2011 May; 17(5):8. PubMed ID: 21766534
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating rheumatoid arthritis.
    Emery P; Kvien TK
    BMJ; 2007 Jul; 335(7610):56-7. PubMed ID: 17626917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Financial interests characterize published reports on coxiber. Whom can we rely on?].
    Håkansson J
    Lakartidningen; 2002 Oct; 99(40):3930-1. PubMed ID: 12422746
    [No Abstract]   [Full Text] [Related]  

  • 15. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
    James JS
    AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Will our current success in treating rheumatoid arthritis hinder new drug development? That is the question!!
    Weinblatt ME
    Ann Rheum Dis; 2005 Nov; 64(11):1529-31. PubMed ID: 16126790
    [No Abstract]   [Full Text] [Related]  

  • 17. Technology evaluation: Belatacept, Bristol-Myers Squibb.
    Vanhove B; Soulillou JP
    Curr Opin Mol Ther; 2005 Aug; 7(4):384-93. PubMed ID: 16121705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bristol-Myers Squibb drug information department services.
    Sylvan L; Palmer-Shevlin N
    Hosp Pharm; 1995 Jan; 30(1):38-9, 44. PubMed ID: 10139729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study.
    Kary S; Fritz J; Scherer HU; Burmester GR
    Rheumatology (Oxford); 2004 Jul; 43(7):819-20. PubMed ID: 15187247
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thinking on the integrative Chinese and Western medicine in treating rheumatoid arthritis].
    Feng XH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jul; 27(7):585-6. PubMed ID: 17717910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.